OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining AWS Partner Network
OneMedNet (Nasdaq: ONMD), a leader in regulatory-grade Real World Data (RWD), has joined the Amazon Web Services (AWS) Partner Network (APN) and secured a new client, a computational biotechnology organization, through the AWS Marketplace.
The APN is a global community leveraging AWS programs and resources to build, market, and sell offerings.
OneMedNet President and CEO Aaron Green highlighted the anticipated rapid growth and the advantages of being part of the APN, emphasizing access to comprehensive clinical data via the iRWD™ network.
The new client praised the ease of accessing OneMedNet's curated clinical data through the AWS Marketplace, enhancing their research and development capabilities.
- Joined the AWS Partner Network (APN) for expanded market reach.
- Secured a significant new client through the AWS Marketplace.
- Access to AWS's global community and technical advantages.
- Enhanced ability to offer regulatory-grade clinical data across a growing network.
- Positive client feedback on the convenience and user-friendliness of access to data.
- The new client remains undisclosed, which may cause speculation among investors.
- No specific financial details or projections provided regarding the impact of this partnership.
Insights
OneMedNet's recent inclusion in the AWS Partner Network (APN) represents a significant strategic move. By aligning with AWS, a leader in cloud services, OneMedNet can leverage robust resources, infrastructure and global reach. This could translate to better scalability and more efficient data handling, pivotal for a company dealing with vast amounts of clinical data. For investors, this alliance suggests enhanced technological validation and potential for accelerated growth, given AWS's stringent partner requirements. This partnership could also streamline OnMedNet's operations, reducing costs and enhancing data security and reliability.
From a financial perspective, partnering with AWS and securing a new client through their marketplace can have several implications for OneMedNet. This move may lead to increased revenue streams as the AWS Marketplace provides a broad reach, facilitating more customer acquisitions. Additionally, the partnership could reduce marketing and distribution costs by leveraging AWS's established channels. While the financial details of the new client deal are undisclosed, the strategic alignment with AWS likely positions OneMedNet favorably in terms of market perception and investor confidence. The move signals an anticipatory strategy for rapid growth, which can attract more investment and enhance stock performance in the short and long term.
The collaboration between OneMedNet and AWS is likely to impact market dynamics significantly. AWS's expansive customer base and trusted brand can help OneMedNet access a wider array of life science companies and computational biotechnology organizations. This not only broadens OneMedNet's market reach but also enhances its credibility. Furthermore, the AWS Marketplace is known for its streamlined procurement process, which can lead to quicker client acquisitions. For investors, this means a potential acceleration in market penetration and increased adoption of OneMedNet's iRWD™ platform.
Secures new life science company customer through this globally recognized and trusted new channel
MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has joined the Amazon Web Services (“AWS”) Partner Network (“APN”) and secured a significant new iRWD™ client, an undisclosed computational biotechnology organization, via the AWS Marketplace.
The APN is a global community of AWS partners that leverages programs, expertise, and resources to build, market, and sell customer offerings.
“As we enter into a stage of anticipated rapid growth, we are excited to have joined the APN global community, a powerful new channel through which OneMedNet is now able to offer potential new customers comprehensive access to valuable, regulatory-grade clinical data across our growing iRWD™ network,” said Aaron Green, OneMedNet’s President and CEO. “AWS has long been recognized as the leading cloud services provider and it is an honor to meet their rigid standards and bring their technical advantages to OneMedNet customers.”
“Choosing to partner with OneMedNet through the APN was a critical decision for us,” commented senior leadership from the new client company. “The convenience and user-friendly nature of the AWS Marketplace made it incredibly easy to discover and engage with OneMedNet. Working with their team, we were able to access precisely curated clinical data, which was crucial for our research and development initiatives. The responsiveness and expertise of the OneMedNet team have significantly enhanced our capabilities, allowing us to leverage regulatory-grade clinical data with ease.”
About OneMedNet Corporation
OneMedNet provides innovative solutions that unlock the significant value contained within the Real-World Data (“RWD”) repositories of over 1,400 healthcare system and provider sites that currently comprise its iRWD™ network. OneMedNet’s proprietary iRWD™ platform provides secure, comprehensive management of diverse clinical data types, including electronic health records, laboratory results, and uniquely, medical imaging. Employing its robust iRWD™ platform, the Company securely de-identifies, searches, and curates the clinical data, bringing a wealth of internal and third-party research opportunities to its drug, medical device and imaging/diagnostic AI development customers.
OneMedNet’s platform is designed to meet the clinical requirements necessary across various domains, including but not limited to rare diseases, oncology, and cardiology. The Company is committed to delivering precise and robust research support services that span the entire continuum of care. This commitment is a cornerstone of OneMedNet’s strategy to enhance patient outcomes and help pave the next wave of healthcare innovation. For more information, please visit www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Stephen Kilmer, Investor Relations
Phone: 647.872.4849
Email: stephen.kilmer@onemednet.com
Michael Wong, Director of Marketing
Phone: 800.918.7189
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
What is the impact of OneMedNet joining the AWS Partner Network?
What new client did OneMedNet secure through the AWS Marketplace?
How will OneMedNet benefit from the AWS Partner Network?
What feedback did the new client provide about OneMedNet?
